NCT02247583

Investigating Patient Satisfaction With Oral Anti-Cancer Treatment

Investigating Patient Satisfaction With Oral Anti-Cancer Treatment. Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate Aspects of Pharmaceutical Care in Patients With Advanced Renal Cell Carcinoma Treated With an Oral Anti-cancer Drug.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 90 (actual)
• Sponsor: KU Leuven · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Prospective non-interventional non-controlled multicenter observational study to evaluate aspects of pharmaceutical care in patients with advanced renal cell carcinoma treated with an oral anti-cancer drug. The main objective of this study is to evaluate the patient perspective in the treatment of advanced renal cell carcinoma with an oral anti-cancer drug. The following aspects will be investigated: * Intrinsic desire for information about treatment. * Patient satisfaction with treatment information. * Patient satisfaction with treatment. * Medication adherence. * Health-related quality of life. * The role of different health care professionals in the treatment of RCC with oral drugs This study should reveal information necessary for the development of pharmacotherapeutic care concepts that meet the needs of cancer patients treated with an oral anti-cancer drug over a long period.

Conditions

• Clear Cell Renal Cell Carcinoma

Timeline

• Start date: 2011-02-01
• Primary completion: 2013-07-01
• Completion: 2013-07-01
• First posted: 2014-09-25
• Last updated: 2014-09-25

Locations

1 site across 1 country: Belgium